Brandes Investment Partners’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Brandes Investment Partners’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-257,775	Closed	-$310K	–	209
2015 Q2	$310K	Sell	257,775 -778,298	-75%	-$991K	﹤0.01%	146
2015 Q1	$1.1M	Buy	1,036,073 +4,150	+0.4%	+$4.29K	0.02%	111
2014 Q4	$1.13M	Sell	1,031,923 -2,910	-0.3%	-$3.05K	0.02%	114
2014 Q3	$1.12M	Sell	1,034,833 -8,530	-0.8%	-$10.5K	0.01%	113
2014 Q2	$1.08M	Sell	1,043,363 -5,060	-0.5%	-$4.82K	0.01%	114
2014 Q1	$1.08M	Buy	1,048,423 +24,530	+2%	+$25.3K	0.01%	120
2013 Q4	$1.19M	Sell	1,023,893 -3,850	-0.4%	-$5.93K	0.01%	120
2013 Q3	$1.73M	Buy	1,027,743 +1,020	+0.1%	+$1.89K	0.02%	115
2013 Q2	$2.05M	Buy	+1,026,723	New	+$3.01M	0.03%	121

Other funds holding ENZN

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Brandes Investment Partners's ENZN Position: Q3 2015 in Review

Brandes Investment Partners sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 257,775 shares — an estimated $310K sold.

Brandes Investment Partners first reported a position in ENZN in Q2 2013 and held it in 9 quarters. The position peaked at $2.05M in Q2 2013. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

Brandes Investment Partners reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
Brandes Investment Partners sold 257,775 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $310K.
Brandes Investment Partners first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 9 quarters.
Brandes Investment Partners's ENZON PHARMACEUTICALS INC position peaked at $2.05M in Q2 2013.
53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on Brandes Investment Partners's 13F filing for Q3 2015, filed 6 Nov 2015.